Showing results (231-240 of 245) with videos related to
Sort By:
Pageof 25
Aging and Disease|June 23, 2016
Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's DiseaseDaniel O Claassen, David G Dobolyi, David A Isaacs, et al.Biomaterials|July 24, 2015
Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytesYoung Wook Chun, Daniel A Balikov, Tromondae K Feaster, et al.Sensors and Actuators. B, Chemical|June 7, 2021
A bistable, multiport valve enables microformulators creating microclinical analyzers that reveal aberrant glutamate metabolism in astrocytes derived from a tuberous sclerosis patientDusty R Miller, David K Schaffer, M Diana Neely, et al.Metallomics : Integrated Biometal Science|May 19, 2020
Huntington's disease genotype suppresses global manganese-responsive processes in pre-manifest and manifest YAC128 miceAnna C Pfalzer, Jordyn M Wilcox, Simona G Codreanu, et al.Journal of Huntington'S Disease|September 4, 2015
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative PhenotypeMichal Wegrzynowicz, Terry Jo Bichell, Barbara D Soares, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2022
Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington's diseaseGiuseppe Pepe, Luca Capocci, Federico Marracino, et al.Scientific Reports|May 26, 2018
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's diseaseAlba Di Pardo, Enrico Amico, Abdul Basit, et al.Journal of Neuroinflammation|December 14, 2016
Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unitJacquelyn A Brown, Simona G Codreanu, Mingjian Shi, et al.Scientific Reports|July 15, 2017
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's diseaseAlba Di Pardo, Enrico Amico, Abdul Basit, et al.Proceedings of the National Academy of Sciences of the United States of America|October 29, 2015
Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 miceTristano Pancani, Daniel J Foster, Mark S Moehle, et al.Pageof 25